You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
開拓藥業-B(09939.HK)董事會主席、執行董事兼行政總裁童友之博士增持145萬股
格隆匯 04-17 18:22

格隆匯4月17日丨開拓藥業-B(09939.HK)公告,公司董事會獲童友之博士(爲公司董事會主席、執行董事兼行政總裁)通知,其於2025年3月28日通過其全資擁有公司KT International Investment Limited於公開市場以自有資金259,000港元(平均成交價格爲每股1.295港元)增持公司200,000股股份,佔公司於本公告日期已發行股本總額約0.0447%。

此外,童博士行使了根據公司2020年僱員激勵計劃授予的1,250,000份受限制股票單位(對應公司1,250,000股普通股)所賦予的權利(連同股份購買統稱本次增持事項)。該等股票已於2025年3月31日完成歸屬。緊隨本次增持事項後,童博士於合共49,200,270股股份中擁有權益,佔公司於本公告日期已發行股本總額約10.99%。根據公司可獲得的公開資料及就董事會所知,公司仍舊維持已發行股份的充足公衆持股量。

董事會認爲,本次增持事項彰顯童博士對公司的商業化前景及增長潛力的堅定信心以及對公司長期投資價值的充分認可。集團將繼續圍繞皮膚科領域,深耕現有化妝品產品,拓寬產品覆蓋場景,加快推動新化妝品產品,進一步豐富產品矩陣。同時,考慮到功效性原料的市場潛力,公司正在積極開拓KT-939和KX-826化妝品原料市場,尋求與化妝品品牌商的合作機會,持續拓展化妝品原料業務以培育新利潤增長點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account